- English
- Español
- Français (Canada)
- 中文(简体)
- 日本語
- Русский
- Svenska
- Italiano
- Deutsch
- हिंदी
- Português
- العربية
- 한국어
- Nederlands
1 of 1 copy available
1 of 1 copy available
Big Pharma is more interested in profit than health. This was made clear as governments rushed to produce vaccines during the Covid pandemic. Behind the much-trumpeted scientific breakthroughs, major companies found new ways of gouging billions from governments in the West while abandoning the Global South. But this is only the latest episode in a long history of financializing medicine—from Purdue's rapacious marketing of highly addictive OxyContin through Martin Shkreli's hiking the price of a lifesaving drug to the 4.5 million South Africans needlessly deprived of HIV/AIDS medication.
Since the 1990s, Big Pharma has gone out of its way to protect its property through the patent system. As a result, the business has focused not on researching new medicines but on building monopolies. This system has helped restructure our economy away from invention and production in order to benefit financial markets. It has fundamentally reshaped the relationship between richer and poorer countries, as the access to new medicines and the permission to manufacture them is ruthlessly policed. In response, Dearden offers a pathway to a fairer, safer system for all.
-
Creators
-
Publisher
-
Release date
November 14, 2023 -
Formats
-
OverDrive Listen audiobook
- ISBN: 9798350870213
- File size: 287822 KB
- Duration: 09:59:37
-
-
Languages
- English
Formats
- OverDrive Listen audiobook
subjects
Languages
- English
Loading
Why is availability limited?
×Availability can change throughout the month based on the library's budget. You can still place a hold on the title, and your hold will be automatically filled as soon as the title is available again.
The Kindle Book format for this title is not supported on:
×Read-along ebook
×The OverDrive Read format of this ebook has professional narration that plays while you read in your browser. Learn more here.